During the past decade, Optall Vision conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Optall Vision" are "Presbyopia" (3 trials). Many other conditions were trialed in "Optall Vision" in a lesser frequency.

Most popular intervention types in "Optall Vision" are "Drug" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Brimonidine Tartrate" (1 trials), "Compound Pilocarpine, Brimonidine, Oxymetazoline, Hyaluronic acid, Bromfenac" (1 trials), "PBO to control presbyopia symptoms" (1 trials), "Pilocarpine Hydrochloride" (1 trials) and "Pilocarpine, brimonidine, oxymetazoline, hyaluronic acid, bromfenac (PBOHB) compound" (1 trials). Other intervention names were less common.

The vast majority of trials in "Optall Vision" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Optall Vision". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Optall Vision, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Optall Vision, 3 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".